Cargando…
Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
Background. Oxaliplatin-induced peripheral neuropathy (OIPN) is one of the most common side effects of oxaliplatin, which can cause reduction and cessation of oxaliplatin-based chemotherapy and significantly affect patients' quality of life. However, no drug has got recognition to prevent or tr...
Autores principales: | Gu, Zhancheng, Wei, Guoli, Zhu, Liangjun, Zhu, Lingjun, Hu, Jing, Li, Qi, Cai, Guoxiang, Lu, Hong, Liu, Min, Chen, Chen, Ji, Yi, Li, Guochun, Huo, Jiege |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494586/ https://www.ncbi.nlm.nih.gov/pubmed/34630609 http://dx.doi.org/10.1155/2021/5551568 |
Ejemplares similares
-
Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: a prospective cohort study
por: Gu, Zhancheng, et al.
Publicado: (2023) -
Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021) -
Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis
por: Gu, Jialin, et al.
Publicado: (2021) -
The Pharmacological Activity of the Wenjing Decoction in Recurrent Spontaneous Abortion
por: Cao, Linhui, et al.
Publicado: (2021) -
Bibliometric Analysis Reveals a 20-Year Research Trend for Chemotherapy-Induced Peripheral Neuropathy
por: Gu, Jialin, et al.
Publicado: (2022)